ProCE Banner Activity

Key HIV Studies Influencing My Practice Following AIDS 2022—Dr. Chloe Orkin

Multimedia
Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

Released: September 20, 2022

Expiration: September 19, 2023

Share

Faculty

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner

Faculty Disclosure

Primary Author

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, MSD, ViiV Healthcare; researcher: AstraZeneca, Gilead Sciences, Janssen, MSD, ViiV Healthcare.